Inventor profile of:

Martin C. WRIGHT

City:

Belmont, Massachusetts

Country:

United States

Published Applications:

15

Last publication date:

2022-11-03

Top Assignees for applications by Martin C. WRIGHT

The entities that hold a legal rights for patent applications filed by inventor WRIGHT Martin C.:

Recent patent applications by WRIGHT Martin C.

Martin C. WRIGHT from Belmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-11-03
US20220347324A1
Human necessities

PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES

#2 | 2022-01-06
US20220001040A1
Human necessities

PD-L1 binding polypeptides for imaging

#3 | 2019-11-14
US20190343972A1
Human necessities

PD-L1 binding polypeptides for imaging

#4 | 2019-07-04
US20190202894A1
Chemistry; metallurgy

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

#5 | 2019-06-20
US20190184042A1
Human necessities

PET imaging with PD-L1 binding polypeptides

#6 | 2019-05-23
US20190153069A1
Chemistry; metallurgy

Bispecific EGFR/IGFIR binding molecules

#7 | 2018-06-14
US20180162926A1
Chemistry; metallurgy

Libraries of modified fibronectin type III tenth domain-containing polypeptides

#8 | 2018-02-08
US20180037631A1
Chemistry; metallurgy

Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules

#9 | 2017-09-14
US20170258948A1
Human necessities

PD-L1 binding polypeptides for imaging

#10 | 2017-07-06
US20170190761A1
Chemistry; metallurgy

Methods of treating cancer by administering IGF-IR binding molecules

#11 | 2016-10-13
US20160297869A1
Chemistry; metallurgy

Inhibitors of type 2 vascular endothelial growth factor receptors

#12 | 2015-09-17
US20150259398A1
Chemistry; metallurgy

Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules

#13 | 2015-09-10
US20150252097A1
Chemistry; metallurgy

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR

#14 | 2013-11-21
US20130310317A1
Human necessities

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR

#15 | 2013-06-20
US20130157948A1
Chemistry; metallurgy

Bispecific EGFR/IGFIR binding molecules

InventorID:

539571 ⎘